SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo

Biochemical and Biophysical Research Communications

Volumn 460, Issue 4, 2015, Pages 903-908

  Yang, Li ^a   Weng, Wei ^a   Sun, Zhi Xin ^a   Fu, Xian Jie ^a   Ma, Jun ^a   Zhuang, Wen Fang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute myeloid leukemia; Ceramide; Chemotherapy; SKI II; Sphingosine kinase 1

Indexed keywords

ENZYME INHIBITOR; PHOSPHOTRANSFERASE; SPHINGOSINE KINASE;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL DIVISION; DRUG EFFECTS; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; HUMAN; IN VITRO STUDY; METABOLISM; MOUSE; PATHOLOGY; SCID MOUSE; TUMOR CELL CULTURE;

ANIMALS; APOPTOSIS; CELL DIVISION; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IN VITRO TECHNIQUES; LEUKEMIA, MYELOID, ACUTE; MICE; MICE, SCID; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84937765177     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.03.114     Document Type: Article

References (34)

1. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA Cancer J. Clin. 64 2014 9 29
2. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J. Clin. 62 2012 10 29
3. J. Zhang, L. Ding, L. Holmfeldt, G. Wu, S.L. Heatley, D. Payne-Turner, J. Easton, X. Chen, J. Wang, M. Rusch, C. Lu, S.C. Chen, L. Wei, J.R. Collins-Underwood, J. Ma, K.G. Roberts, S.B. Pounds, A. Ulyanov, J. Becksfort, P. Gupta, R. Huether, R.W. Kriwacki, M. Parker, D.J. McGoldrick, D. Zhao, D. Alford, S. Espy, K.C. Bobba, G. Song, D. Pei, C. Cheng, S. Roberts, M.I. Barbato, D. Campana, E. Coustan-Smith, S.A. Shurtleff, S.C. Raimondi, M. Kleppe, J. Cools, K.A. Shimano, M.L. Hermiston, S. Doulatov, K. Eppert, E. Laurenti, F. Notta, J.E. Dick, G. Basso, S.P. Hunger, M.L. Loh, M. Devidas, B. Wood, S. Winter, K.P. Dunsmore, R.S. Fulton, L.L. Fulton, X. Hong, C.C. Harris, D.J. Dooling, K. Ochoa, K.J. Johnson, J.C. Obenauer, W.E. Evans, C.H. Pui, C.W. Naeve, T.J. Ley, E.R. Mardis, R.K. Wilson, J.R. Downing, and C.G. Mullighan The genetic basis of early T-cell precursor acute lymphoblastic leukaemia Nature 481 2012 157 163
4. J.P. Patel, M. Gonen, M.E. Figueroa, H. Fernandez, Z. Sun, J. Racevskis, P. Van Vlierberghe, I. Dolgalev, S. Thomas, O. Aminova, K. Huberman, J. Cheng, A. Viale, N.D. Socci, A. Heguy, A. Cherry, G. Vance, R.R. Higgins, R.P. Ketterling, R.E. Gallagher, M. Litzow, M.R. van den Brink, H.M. Lazarus, J.M. Rowe, S. Luger, A. Ferrando, E. Paietta, M.S. Tallman, A. Melnick, O. Abdel-Wahab, and R.L. Levine Prognostic relevance of integrated genetic profiling in acute myeloid leukemia N. Engl. J. Med. 366 2012 1079 1089
5. A. Renneville, C. Roumier, V. Biggio, O. Nibourel, N. Boissel, P. Fenaux, and C. Preudhomme Cooperating gene mutations in acute myeloid leukemia: a review of the literature Leukemia 22 2008 915 931
6. M.M. Young, M. Kester, and H.G. Wang Sphingolipids: regulators of crosstalk between apoptosis and autophagy J. Lipid Res. 54 2013 5 19
7. B. Ogretmen, and Y.A. Hannun Biologically active sphingolipids in cancer pathogenesis and treatment Nat. Rev. Cancer 4 2004 604 616
8. P. Gangoiti, M.H. Granado, A. Alonso, F.M. Goni, and A. Gomez-Munoz Implication of ceramide, ceramide 1-phosphate and sphingosine 1-phosphate in tumorigenesis Transl. Oncogenomics 3 2008 81 98
9. M. Maceyka, K.B. Harikumar, S. Milstien, and S. Spiegel Sphingosine-1-phosphate signaling and its role in disease Trends Cell Biol. 22 2012 50 60
10. M.T. Dimanche-Boitrel, A. Rebillard, and E. Gulbins Ceramide in chemotherapy of tumors Recent Pat. Anticancer Drug Discov. 6 2011 284 293
11. Y. Edmonds, S. Milstien, and S. Spiegel Development of small-molecule inhibitors of sphingosine-1-phosphate signaling Pharmacol. Ther. 132 2011 352 360
12. M. Vadas, P. Xia, G. McCaughan, and J. Gamble The role of sphingosine kinase 1 in cancer: oncogene or non-oncogene addiction? Biochim. Biophys. Acta 1781 2008 442 447
13. D. Shida, K. Takabe, D. Kapitonov, S. Milstien, and S. Spiegel Targeting SphK1 as a new strategy against cancer Curr. Drug Targets 9 2008 662 673
14. S.W. Paugh, B.S. Paugh, M. Rahmani, D. Kapitonov, J.A. Almenara, T. Kordula, S. Milstien, J.K. Adams, R.E. Zipkin, S. Grant, and S. Spiegel A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia Blood 112 2008 1382 1391
15. P. Neviani, R. Santhanam, J.J. Oaks, A.M. Eiring, M. Notari, B.W. Blaser, S. Liu, R. Trotta, N. Muthusamy, C. Gambacorti-Passerini, B.J. Druker, J. Cortes, G. Marcucci, C.S. Chen, N.M. Verrills, D.C. Roy, M.A. Caligiuri, C.D. Bloomfield, J.C. Byrd, and D. Perrotti FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia J. Clin. Invest. 117 2007 2408 2421
16. Y. Chiba, H. Takeuchi, H. Sakai, and M. Misawa SKI-II, an inhibitor of sphingosine kinase, ameliorates antigen-induced bronchial smooth muscle hyperresponsiveness, but not airway inflammation, in mice J. Pharmacol. Sci. 114 2010 304 310
17. C. Zhang, H. He, H. Zhang, D. Yu, W. Zhao, Y. Chen, and R. Shao The blockage of Ras/ERK pathway augments the sensitivity of SphK1 inhibitor SKI II in human hepatoma HepG2 cells Biochem. Biophys. Res. Commun. 434 2013 35 41
18. D. Pchejetski, T. Bohler, L. Brizuela, L. Sauer, N. Doumerc, M. Golzio, V. Salunkhe, J. Teissie, B. Malavaud, J. Waxman, and O. Cuvillier FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1 Cancer Res. 70 2010 8651 8661
19. J. Taipale, and P.A. Beachy The Hedgehog and Wnt signalling pathways in cancer Nature 411 2001 349 354
20. B.M. Altura, N.C. Shah, G.J. Shah, A. Zhang, W. Li, T. Zheng, J.L. Perez-Albela, and B.T. Altura Short-term Mg deficiency upregulates protein kinase C isoforms in cardiovascular tissues and cells; relation to NF-kB, cytokines, ceramide salvage sphingolipid pathway and PKC-zeta: hypothesis and review Int. J. Clin. Exp. Med. 7 2014 1 21
21. L. Gong, B. Yang, M. Xu, B. Cheng, X. Tang, P. Zheng, Y. Jing, and G.J. Wu Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production Cancer Chemother. Pharmacol. 73 2014 69 77
22. W.Y. Sun, L.D. Abeynaike, S. Escarbe, C.D. Smith, S.M. Pitson, M.J. Hickey, and C.S. Bonder Rapid histamine-induced neutrophil recruitment is sphingosine kinase-1 dependent Am. J. Pathol. 180 2012 1740 1750
23. M. Kim, N. Kim, V.D. D'Agati, C.W. Emala Sr., and H.T. Lee Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways Am. J. Physiol. Ren. Physiol. 293 2007 F1827 F1835
24. T.D. Mullen, and L.M. Obeid Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death Anticancer Agents Med. Chem. 12 2012 340 363
25. S. Ponnusamy, M. Meyers-Needham, C.E. Senkal, S.A. Saddoughi, D. Sentelle, S.P. Selvam, A. Salas, and B. Ogretmen Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance Future Oncol. 6 2010 1603 1624
26. N.S. Radin Killing tumours by ceramide-induced apoptosis: a critique of available drugs Biochem. J. 371 2003 243 256
27. N.S. Radin Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come? Eur. J. Biochem. 268 2001 193 204
28. G.S. Dbaibo, and Y.A. Hannun Signal transduction and the regulation of apoptosis: roles of ceramide Apoptosis 3 1998 317 334
29. F. Thayyullathil, S. Chathoth, J. Kizhakkayil, A. Galadari, A. Hago, M. Patel, and S. Galadari Glutathione selectively inhibits Doxorubicin induced phosphorylation of p53Ser(15), caspase dependent ceramide production and apoptosis in human leukemic cells Biochem. Biophys. Res. Commun. 411 2011 1 6
30. W.C. Huang, C.C. Tsai, C.L. Chen, T.Y. Chen, Y.P. Chen, Y.S. Lin, P.J. Lu, C.M. Lin, S.H. Wang, C.W. Tsao, C.Y. Wang, Y.L. Cheng, C.Y. Hsieh, P.C. Tseng, and C.F. Lin Glucosylceramide synthase inhibitor PDMP sensitizes chronic myeloid leukemia T315I mutant to Bcr-Abl inhibitor and cooperatively induces glycogen synthase kinase-3-regulated apoptosis FASEB J. 25 2011 3661 3673
31. D. Myrick, D. Blackinton, J. Klostergaard, N. Kouttab, A. Maizel, H. Wanebo, and S. Mehta Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide Leuk. Res. 23 1999 569 578
32. P.H. Li, J.X. Wu, J.N. Zheng, and D.S. Pei A sphingosine kinase-1 inhibitor, SKI-II, induces growth inhibition and apoptosis in human gastric cancer cells Asian Pac. J. Cancer Prev. 15 2014 10381 10385
33. C. Schiefler, G. Piontek, J. Doescher, D. Schuettler, M. Misslbeck, M. Rudelius, A. Haug, R. Reiter, G. Brockhoff, and A. Pickhard Inhibition of SphK1 reduces radiation-induced migration and enhances sensitivity to cetuximab treatment by affecting the EGFR/SphK1 crosstalk Oncotarget 5 2014 9877 9888
34. J.W. Antoon, W.D. Meacham, M.R. Bratton, E.M. Slaughter, L.V. Rhodes, H.B. Ashe, T.E. Wiese, M.E. Burow, and B.S. Beckman Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer J. Mol. Endocrinol. 46 2011 205 216